Article

Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-Analysis

2020-10-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Erenumab is a novel monoclonal calcitonin gene–related peptide receptor antibody that is used for the preventive treatment of migraine.<bold>Objectives </bold>To evaluate overall safety and efficacy and dose-response relationship of erenumab in patients with episodic migraine and patients with prior migraine treatment failures.<bold>Methods</bold> We searched ran...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2a36afaf-c0c6-5717-a575-f6268e5e78c0
DOI: 10.21203/rs.3.rs-87163/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Different Doses of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Network Meta-AnalysisDOI 10.21203/rs.3.rs-87163/v1Read

Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity Read

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read

Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity Read

Real-world experience of erenumab in patients with chronic or episodic migraine in the UAESemantic proximity Read

Real-world Evidence Data on the Monoclonal Antibody Erenumab in Migraine Prevention: Perspectives of Treating Physicians in GermanySemantic proximity Read

Comparative Efficacy and Safety of Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Oral Gepants for Episodic Migraine Prevention: A Bayesian Network Meta-Analysis of Randomized Controlled TrialsSemantic proximity Read

The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysisSemantic proximity Read

Erenumab in highly therapy-refractory migraine patients First German Real-world evidenceSemantic proximity Read

Different Dosage Regimens of Eptinezumab for the Treatment of Migraine: A Meta-Analysis from Randomized Controlled TrialsSemantic proximity Read

Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity Read

Safety and Efficacy of Fremanezumab for the Prevention of Migraine: a Meta-analysis from Random Clinical TrailsSemantic proximity Read

Atogepant: Mechanism of action, clinical and translational scienceSemantic proximity Read